Table 1.

Cohort patient demographics

Patient	Age (years)	Sex	Race	BSA (m2)	Concurrent Therapy	No. of Studies*
1	6.6	M	H	0.81	Dex, DPH	4
2	8.4	M	AA	0.96	--	4
3	3.6	F	H	0.67	Dex	3
4	4.8	M	C	0.97	Dex	2
5	3.2	M	C	0.61	Dex	3
6	4.9	M	AA	1.00	Dex	2

Abbreviations: AA, African American; BSA, body surface area; C, Caucasian; Dex, dexamethasone; DPH, diphenylhydantoin (phenytoin); F, female; H, Hispanic; M, male.

^*Number of plasma and ventricular cerebrospinal fluid studies.